Zhongchao Inc. (ZCMD): Price and Financial Metrics
ZCMD Stock Summary
- With a one year PEG ratio of 1.01, Zhongchao Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than just 6.96% of US stocks.
- Zhongchao Inc's stock had its IPO on February 24, 2020, making it an older stock than only 0.3% of US equities in our set.
- With a year-over-year growth in debt of -65.41%, Zhongchao Inc's debt growth rate surpasses just 4.53% of about US stocks.
- Stocks that are quantitatively similar to ZCMD, based on their financial statements, market capitalization, and price volatility, are JOUT, CTK, TOUR, BRC, and EFOI.
- Visit ZCMD's SEC page to see the company's official filings. To visit the company's web site, go to www.izcmd.com.
ZCMD Stock Price Chart Interactive Chart >
ZCMD Price/Volume Stats
| Current price | $1.84 | 52-week high | $5.25 |
| Prev. close | $1.84 | 52-week low | $1.59 |
| Day low | $1.81 | Volume | 92,800 |
| Day high | $1.94 | Avg. volume | 2,317,990 |
| 50-day MA | $2.02 | Dividend yield | N/A |
| 200-day MA | $1.98 | Market Cap | 35.15M |
Zhongchao Inc. (ZCMD) Company Bio
Zhongchao, Inc. is a holding company that engages in the provision of healthcare information, education, and training services. It offers online and onsite health information services, healthcare education programs, and healthcare training products, consisting primarily of clinical practice training, open classes of medical topics, interactive case studies, academic conference & workshops, continuing education courses, articles & short videos with educational healthcare content to healthcare professionals as well as the public. The company was founded by Wei Guang Yang on April 16, 2019 and is headquartered in Shanghai, China.
Latest ZCMD News From Around the Web
Below are the latest news stories about Zhongchao Inc that investors may wish to consider to help them evaluate ZCMD as an investment opportunity.
Zhongchao, Immatics leads healthcare gainers; SunLink Health Systems, Rubius Therapeutics among major losersGainers: Zhongchao (ZCMD) +53%, Immatics (IMTX) +42%, Lipocine (LPCN) +23%, FSD Pharma (HUGE) +18%, Nabriva Therapeutics (NBRV) +18%.Losers: SunLink Health Systems (SSY) -28%, Rubius Therapeutics (RUBY) -17%, CHF Solutions CHFS -15%, IMV (IMV) -15%, Can-Fite BioPharma (CANF) -11%.... |
Zhongchao Renews Contract with China Association of Health Promotion and Education and GlaxoSmithKlineZhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced the renewal of its partnership with the China Association for Health Promotion and Education and GlaxoSmithKline (China) Investment Limited to continue the medical education program "Pulmonary Arterial Hypertension Online Course – Connections with Famous Hospitals" ("PAH Project") in 2021. |
ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Zhongchao Inc. and Encourages Investors with Losses to Contact the FirmLos Angeles, California--(Newsfile Corp. - March 4, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or "the Company") for violations of the securities laws.The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.If you are a shareholder who suffered a loss, click here to participate.We also ... |
ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Zhongchao Inc. and Encourages Investors with Losses to Contact the FirmThe Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zhongchao Inc. ("Zhongchao" or "the Company") (NASDAQ: ZCMD) for violations of the securities laws. |
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Zhongchao Inc. and Encourages Investors with Losses to Contact the FirmLOS ANGELES, CA / ACCESSWIRE / January 13, 2021 /The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zhongchao Inc. ("Zhongchao" or "the Company") (NASDAQ:ZCMD) for violations of the securities laws. |
ZCMD Price Returns
| 1-mo | 1.10% |
| 3-mo | -1.08% |
| 6-mo | 6.36% |
| 1-year | -23.33% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | 8.24% |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
| 2016 | N/A |
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
Loading social stream, please wait...